ADAM10 and head and neck squamous cell carcinoma: A more recent study reported that miR-144/451 inhibits breast cancer and head and neck squamous cell carcinoma (HNSCC) metastasis by targeting ADAMTS5 and ADAM10, and the overexpression of these two proteins being significantly associated with lymph node metastasis and pathological grade [28].